Trials that use: Logistic regression
New to this method? Read the tutorial →
5,900 results
- High-Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of High-Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00349778).
- High-dose vs. Standard-dose Cephalexin for Cellulitis: Complete Statistical AnalysisIndependent statistical analysis of High-dose vs. Standard-dose Cephalexin for Cellulitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04471246).
- High-Dose Y-90-Ibritumomab Tiuxetan Added to Reduced-Intensity Allogeneic Stem Cell Transplant Regimen for Relapsed or Refractory Aggressive B-Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of High-Dose Y-90-Ibritumomab Tiuxetan Added to Reduced-Intensity Allogeneic Stem Cell Transplant Regimen for Relapsed or Refractory Aggressive B-Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy: Complete Statistical AnalysisIndependent statistical analysis of Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03388619).
- HiLo: Pragmatic Trial of Higher vs Lower Serum Phosphate Targets in Patients Undergoing Hemodialysis: Complete Statistical AnalysisIndependent statistical analysis of HiLo: Pragmatic Trial of Higher vs Lower Serum Phosphate Targets in Patients Undergoing Hemodialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- HIPCVAX-010SIndependent statistical analysis of Durability and Impact of the Seasonal Influenza Vaccine on H5 Induced B Cell Response: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Hippocampal Network Changes Following Mindfulness Training in Tobacco Vaping Adolescents in an Open-label, Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Hippocampal Network Changes Following Mindfulness Training in Tobacco Vaping Adolescents in an Open-label, Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- HiRTIndependent statistical analysis of Hyperglycemia in Renal Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01643382).
- Histologic Assessment of the Difference Between 18F-2-fluoro-2-deoxy_D-glucose Positron Emission Mammography(PEM) and Magnetic Resonance Imaging (MRI) of the Breast: Complete Statistical AnalysisIndependent statistical analysis of Histologic Assessment of the Difference Between 18F-2-fluoro-2-deoxy_D-glucose Positron Emission Mammography(PEM) and Magnetic Resonance Imaging (MRI) of the Breast: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Historical Case Record Survey of Visual Acuity Data From Patients With Leber’s Hereditary Optic Neuropathy (LHON): Complete Statistical AnalysisIndependent statistical analysis of Historical Case Record Survey of Visual Acuity Data From Patients With Leber's Hereditary Optic Neuropathy (LHON): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- HITCHIndependent statistical analysis of Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- HIV and Kidney Function Study: Complete Statistical AnalysisIndependent statistical analysis of HIV and Kidney Function Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00905151).
- HIV Self Testing of Male Partners of Women in PMTCT: Complete Statistical AnalysisIndependent statistical analysis of HIV Self Testing of Male Partners of Women in PMTCT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03484533).
- HIV Vaccine Trial in Thai Adults: Complete Statistical AnalysisIndependent statistical analysis of HIV Vaccine Trial in Thai Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00223080).
- HM2014-26 DT2219 for Relapsed or Refractory B-Lineage Leukemia or Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of HM2014-26 DT2219 for Relapsed or Refractory B-Lineage Leukemia or Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02370160).
- HNSCCIndependent statistical analysis of Single-arm Study With Bimiralisib in Patients With HNSCC Harboring NOTCH1 Loss of Function Mutations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE): Complete Statistical AnalysisIndependent statistical analysis of Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02798471).
- HOMEIndependent statistical analysis of Improving Health Outcomes and Equity by Targeting Postpartum Mothers at Highest Risk: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Home-based Delivery of the Contraceptive Implant in Postpartum Guatemalan Women: Complete Statistical AnalysisIndependent statistical analysis of Home-based Delivery of the Contraceptive Implant in Postpartum Guatemalan Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04005391).
- Home-based Digital Exercise Training Program to Improve Physical Function of Older Sepsis Survivors – HEAL Sepsis Trial: Complete Statistical AnalysisIndependent statistical analysis of Home-based Digital Exercise Training Program to Improve Physical Function of Older Sepsis Survivors - HEAL Sepsis Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Home-based Transcranial Direct Current Stimulation (tDCS) for Behavioral Symptoms in Alzheimer’s Disease and Related Dementias (ADRD): Complete Statistical AnalysisIndependent statistical analysis of Home-based Transcranial Direct Current Stimulation (tDCS) for Behavioral Symptoms in Alzheimer's Disease and Related Dementias (ADRD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Homeopathic Cold Medicine for Children: Complete Statistical AnalysisIndependent statistical analysis of Homeopathic Cold Medicine for Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00858494).
- HOP-2AIndependent statistical analysis of HOP-2A - Intratesticular Hormone Levels: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00756561).
- HOP-3Independent statistical analysis of HOP-3 Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00839319).
- HOPE-2-OLEIndependent statistical analysis of Open-label Extension of the HOPE-2 Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04428476).
- HORIZON 2Independent statistical analysis of A Study to Evaluate Different Dose Levels of Ad26.COV2.S in Healthy Adolescents From 12 to 17 Years Inclusive: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Hormone Replacement and Neural Cardiovascular Control in Postmenopausal Women: Complete Statistical AnalysisIndependent statistical analysis of Hormone Replacement and Neural Cardiovascular Control in Postmenopausal Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01633814).
- Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Hospital Waterbirth Trial to Measure Maternal and Neonatal Outcomes: Complete Statistical AnalysisIndependent statistical analysis of Hospital Waterbirth Trial to Measure Maternal and Neonatal Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05175599).
- HPV Vaccine Intervention for Young Sexual Minority Men: Complete Statistical AnalysisIndependent statistical analysis of HPV Vaccine Intervention for Young Sexual Minority Men: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04032106).
- HRVIndependent statistical analysis of Heart Rate Variability in Trauma Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00795535).
- HSCT for High Risk Inherited Inborn Errors: Complete Statistical AnalysisIndependent statistical analysis of HSCT for High Risk Inherited Inborn Errors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00383448).
- HSG and Tubal Patency Study: Complete Statistical AnalysisIndependent statistical analysis of HSG and Tubal Patency Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02146248).
- HSIIndependent statistical analysis of Home Safety Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06216327).
- HSPvsHSPASIIndependent statistical analysis of Hot Snare Versus Hot Snare Polypectomy With Saline Injection for Colorectal Polyps: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- HUCSIndependent statistical analysis of Human Use Condition Study- Evaluation of Implanted Leads in Humans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04320849).
- HUM21469Independent statistical analysis of Palonosetron for the Treatment of Nausea and Vomiting in Terminally Ill Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Human Amniotic Membrane to Decrease Post Operative Atrial Fibrillation: Complete Statistical AnalysisIndependent statistical analysis of Human Amniotic Membrane to Decrease Post Operative Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04130061).
- Human Factor Validation of Pediatric Mobility Device: Complete Statistical AnalysisIndependent statistical analysis of Human Factor Validation of Pediatric Mobility Device: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03714256).
- Human Factors Study to Validate the User Interface of TOBI Podhaler Using Placebo Capsules: Complete Statistical AnalysisIndependent statistical analysis of Human Factors Study to Validate the User Interface of TOBI Podhaler Using Placebo Capsules: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction: Complete Statistical AnalysisIndependent statistical analysis of Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Human Participant Study of Prototype Non-medicated Multilayer Foam Dressings on Intact Skin: Complete Statistical AnalysisIndependent statistical analysis of Human Participant Study of Prototype Non-medicated Multilayer Foam Dressings on Intact Skin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- HUMBOLDTIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of Filgotinib in Adults With Active Noninfectious Uveitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- HVTN 120Independent statistical analysis of Evaluating the Safety and Immunogenicity of ALVAC-HIV and MF59®- or AS01B-adjuvanted Bivalent Subtype C gp120 in Healthy, HIV-uninfected Adult Participants: primary endpoint results, effect estimate with confidence interval,…
- HW005Independent statistical analysis of Clinical Evaluation of HW005 Ventricular Assist System for the Treatment of Advanced Heart Failure in Japan: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence: Complete Statistical AnalysisIndependent statistical analysis of Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01609842).
- HyCoSyIndependent statistical analysis of Can SIS Using Air Bubbles Replace HSG for Fallopian Tubal Patency After Essure Placement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Hydrocortisone for BPD: Complete Statistical AnalysisIndependent statistical analysis of Hydrocortisone for BPD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01353313).
- Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection: Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04372017).